KLIFS: a knowledge-based structural database to navigate kinase–ligand interaction space OPJ Van Linden, AJ Kooistra, R Leurs, IJP De Esch, C De Graaf Journal of medicinal chemistry 57 (2), 249-277, 2014 | 295 | 2014 |
KLIFS: a structural kinase-ligand interaction database AJ Kooistra, GK Kanev, OPJ van Linden, R Leurs, IJP de Esch, C de Graaf Nucleic acids research 44 (D1), D365-D371, 2016 | 163 | 2016 |
Perspectives of postmenopausal breast cancer survivors on adjuvant endocrine therapy-related symptoms GJ van Londen, HS Donovan, EB Beckjord, AL Cardy, DH Bovbjerg, ... Oncology nursing forum 41 (6), 660, 2014 | 41 | 2014 |
Fragment based lead discovery of small molecule inhibitors for the EPHA4 receptor tyrosine kinase OPJ Van Linden, C Farenc, WH Zoutman, L Hameetman, M Wijtmans, ... European journal of medicinal chemistry 47, 493-500, 2012 | 37 | 2012 |
Regiochemistry of the Condensation of 2-Aroyl-cyclohexanones and 2-Cyanoacetamide: 13C-Labeling Studies and Semiempirical MO Calculations OPJ van Linden, M Wijtmans, L Roumen, L Rotteveel, R Leurs, ... The Journal of Organic Chemistry 77 (17), 7355-7363, 2012 | 12 | 2012 |
Fragment-based drug design of small molecule EPHA4 kinase inhibitors OPJ van Linden | 1 | 2013 |
Regiochemistry of the condensation of 2-aroyl-cyclohexanones and 2-cyanoacetamide OPJ van Linden, M Wijtmans, L Roumen, L Rotteveel, R Leurs, ... | | |
Fragment–based drug design of small molecule EPHA4 kinase inhibitors LM Bouter, OPJ van Linden | | |